Nakamoto Inc.

Financial Services

NASDAQ:NAKA · NASDAQ Global Market

Market Cap $4.07B Beta -0.90 P/E (TTM) -0.2

$4.21 +0.03%

+$0.00 today

52W Low $4.05High $679.20

Vol 0.17M · Avg 0.24M

EPS (TTM) -$18.22Financial - Capital Markets

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-99.35%

Period High

$652.00

Period Low

$4.08

Latest

$4.21

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Agilon Health, Inc.

NYSE:AGL

$1.76B

Delcath Systems, Inc.

NASDAQ:DCTH

$410.50M

DBV Technologies S.A.

NASDAQ:DBVT

$387.33M

SOPHiA GENETICS S.A.

NASDAQ:SOPH

$379.41M

Simulations Plus, Inc.

NASDAQ:SLP

$368.69M

Amarin Corporation plc

NASDAQ:AMRN

$326.79M

Cellectis S.A.

NASDAQ:CLLS

$310.29M

Larimar Therapeutics, Inc.

NASDAQ:LRMR

$306.08M

Lyell Immunopharma, Inc.

NASDAQ:LYEL

$297.16M

Definitive Healthcare Corp.

NASDAQ:DH

$84.30M

What is the latest NAKA filing?

The latest filing shown is 8-K dated Jun 11, 2026.

How many recent filings does NAKA have?

Intrinsic Alpha currently shows 20 recent filings for NAKA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.